Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc.verified

CRVS

Price:

$8.95

Market Cap:

$575.10M

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for p...[Read more]

Industry

Biotechnology

IPO Date

2016-03-23

Stock Exchange

NASDAQ

Ticker

CRVS

The Current Ratio as of November 2024 (TTM) for Corvus Pharmaceuticals, Inc. (CRVS) is 0.92

According to Corvus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.92. This represents a change of -69.21% compared to the average of 3.00 of the last 4 quarters.

Corvus Pharmaceuticals, Inc. (CRVS) Historical Current Ratio (quarterly & annually)

How has CRVS Current Ratio performed in the past?

The mean historical Current Ratio of Corvus Pharmaceuticals, Inc. over the last ten years is 10.05. The current 0.92 Current Ratio has changed 820.19% with respect to the historical average. Over the past ten years (40 quarters), CRVS's Current Ratio was at its highest in in the September 2015 quarter at 111.05. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Quarterly (TTM)
Annual

Average

10.05

Median

5.94

Minimum

3.31

Maximum

31.16

Corvus Pharmaceuticals, Inc. (CRVS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Corvus Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 565.04%

Maximum Annual Current Ratio = 31.16

Minimum Annual Increase = -57.13%

Minimum Annual Current Ratio = 3.31

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.0716.65%
20223.49-38.25%
20215.6570.81%
20203.31-46.83%
20196.22-57.13%
201814.5160.19%
20179.06-50.64%
201618.36-41.09%
201531.16565.04%

Corvus Pharmaceuticals, Inc. (CRVS) Average Current Ratio

How has CRVS Current Ratio performed in the past?

The current Current Ratio of Corvus Pharmaceuticals, Inc. (CRVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.40

5-year avg

4.55

10-year avg

10.05

Corvus Pharmaceuticals, Inc. (CRVS) Current Ratio vs. Peers

How is CRVS’s Current Ratio compared to its peers?

Corvus Pharmaceuticals, Inc.’s Current Ratio is less than Mereo BioPharma Group plc (6.10), less than Terns Pharmaceuticals, Inc. (32.99), less than PDS Biotechnology Corporation (2.84), less than Inozyme Pharma, Inc. (7.68), less than HOOKIPA Pharma Inc. (3.26), less than X4 Pharmaceuticals, Inc. (4.89), less than Day One Biopharmaceuticals, Inc. (14.62), less than Acumen Pharmaceuticals, Inc. (10.43),

Build a custom stock screener for Corvus Pharmaceuticals, Inc. (CRVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corvus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corvus Pharmaceuticals, Inc. (CRVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corvus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Corvus Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Corvus Pharmaceuticals, Inc. (CRVS)?

What is the highest Current Ratio for Corvus Pharmaceuticals, Inc. (CRVS)?

What is the 3-year average Current Ratio for Corvus Pharmaceuticals, Inc. (CRVS)?

What is the 5-year average Current Ratio for Corvus Pharmaceuticals, Inc. (CRVS)?

How does the current Current Ratio for Corvus Pharmaceuticals, Inc. (CRVS) compare to its historical average?